As the antigens targeted by CARs can serve as critical signaling molecules in cancer cells (e.g., mesothelin in solid tumors or BCMA in plasma cells) [114, 115], the capture of target-associated molecules by NK or T cells via trogocytosis may potentially modify the cellular function of CAR-expressing cells. This evidence concerns the gene TNFRSF17 and cancer.